Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia
Alexandros Rouvas,1 Panagiotis Malamos,2 Maria Douvali,1 Amalia Ntouraki,1 Nikos N Markomichelakis1 12nd Department of Ophthalmology, Medical School of Athens University, Athens, Greece; 2Department of Ophthalmology, NHS, “G Gennimatas” General Hospital, Athens, Greece Aims: To r...
Enregistré dans:
Auteurs principaux: | Rouvas A, Malamos P, Douvali M, Ntouraki A, Markomichelakis NN |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9038c04193f04c11bfedeed4ddc1fe53 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2016) -
Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection
par: Kugu S, et autres
Publié: (2012) -
Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
par: Takayama K, et autres
Publié: (2012) -
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
par: Ellabban AA, et autres
Publié: (2012) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
par: Karagiannis D, et autres
Publié: (2017)